Sodium fusidate in Guillain-Barre syndrome: a case report (original) (raw)
Amelioration of Experimental Allergic Neuritis by Sodium Fusidate (Fusidin): Suppression of IFN-γ and TNF-α and Enhancement of IL-10
Saad Muhallab
Journal of Autoimmunity, 1999
View PDFchevron_right
Biological drugs in Guillain-Barré Syndrome: an update
Giovanna Vitaliti
Current Neuropharmacology, 2016
View PDFchevron_right
Guillain-Barré syndrome: epidemiology, pathophysiology and management
Satoshi Kuwabara
Drugs
View PDFchevron_right
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
Adriano Vieira, Bart Jacobs
View PDFchevron_right
Practice parameter: Immunotherapy for Guillain-Barre syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology
R Barohn
Neurology, 2003
View PDFchevron_right
Guillain-Barré Syndrome: Causes, Epidemiology, Immunopathogenic Mechanisms, Diagnosis, Evaluation, Differential and Treatment
Carla Idrovo
EPRA International Journal of Multidisciplinary Research (IJMR)
View PDFchevron_right
Fulminant Guillain-Barré Syndrome (GBS) with a Constellation of Uncommon Clinical Manifestations: Differential Diagnosis and Treatment Challenges
Hilal Abdessamad
Journal of Case Reports
View PDFchevron_right
Guillain—Barré syndrome: biological basis, treatment and care
Kate mcmahon-parkes
Intensive and Critical Care Nursing, 1997
View PDFchevron_right
Rescue treatment in patients with poorly responsive Guillain–Barre syndrome
Ayman Alboudi
SAGE Open Medicine
View PDFchevron_right
Comparative study of various therapeutic modalities for guillain barré syndrome in assiut university children hospital
Professor Khaled Saad
The Turkish Journal of Pediatrics, 2020
View PDFchevron_right
Guillain-Barré syndrome: an update
Ostoja Steve Vucic
Journal of Clinical Neuroscience, 2009
View PDFchevron_right
Gabapentin for the Treatment of Pain in Guillain-Barré Syndrome: A Double-Blinded, Placebo-Controlled, Crossover Study
Chandra Kant Pandey
Anesthesia & Analgesia, 2002
View PDFchevron_right
Guillain-Barre Syndrome and its Variants: Clinical Course and Prognostic Factors
gulsun ersen
Noro Psikiyatri Arsivi, 2017
View PDFchevron_right
A Systematic Review on Immunotherapy for Guillain- Barre Syndrome
Abu Nayeem
Journal of Bangladesh College of Physicians and Surgeons, 2022
View PDFchevron_right
Guillain Barre Syndrome, the Therapeutic Outcomes Pak Armed Forces Med
Nadia Shams
2015
View PDFchevron_right
Gamunex® in Guillain-Barré Syndrome: A Postmarketing, Retrospective, Observational Study
Zaeem Siddiqi
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
View PDFchevron_right
Disease profile of Guillain-Barré syndrome among Indian patients receiving intravenous immunoglobulin: a real-world observational study
Lav Patel
International Journal of Scientific Reports, 2022
View PDFchevron_right
Clinical Outcome of Intravenous Immunoglobulin in the treatment of Guillain Barre Syndrome in a Nepalese Tertiary Centre
Dr. Ragesh karn
Nepalese Medical Journal
View PDFchevron_right
Treatment of Guillain-Barre syndrome with anti-T cell monoclonal antibodies
Thomas Feasby
Journal of Neurology, Neurosurgery & Psychiatry, 1991
View PDFchevron_right
Non-TH1 cytokines are augmented systematically early in Guillain-Barre syndrome
Volkan Ozenci
Neurology, 2002
View PDFchevron_right
Guillain Barre Syndrome: A Retrospective Study of Ten Years
Sahar Khoshravesh
View PDFchevron_right
Guillain–Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy
Bouchra Amine
Clinical Rheumatology, 2009
View PDFchevron_right
Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome
C. Sindic
Journal of the Neurological Sciences, 1991
View PDFchevron_right
High and Low Dose Ivig Therapy in Guillain- Barre-Syndrome Children: A Comparison
Parvaneh Karimzadeh
Iranian journal of child neurology, 2006
View PDFchevron_right
The management of Guillain–Barré syndrome
William Whitehouse
Current Paediatrics, 2004
View PDFchevron_right
Severe Guillain–Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based review
Bonifacio Alvarez Lario
Clinical Rheumatology, 2013
View PDFchevron_right
Clinical Features and Outcome of the Guillain–Barre Syndrome: A Single-Center 11-Year Experience
Federica Ginanneschi
Frontiers in Neurology
View PDFchevron_right
Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barré Syndrome
Guy Gorochov, Sophie Demeret
PLoS ONE, 2008
View PDFchevron_right
Guillain-Barré syndrome: Clinical profile and Consensus to revise Hughes grade 5
Sandhya Manorenj, Devender Arelli
International Journal of Medicine and Public Health, 2016
View PDFchevron_right
Impact of IVIG in the Management of Guillain-Barre Syndrome: A Case Series from South India
Dinesh Kumar
Journal of Drug Delivery and Therapeutics
View PDFchevron_right